Bone Regeneration and Ageing

Bone is one of the few adult tissues capable of repairing a substantial injury without permanently replacing the damaged region with scar alone. In common forms of fracture healing, a temporary organ called the callus coordinates immune cells, skeletal progenitors, cartilage, blood vessels, osteoblasts, and osteoclasts before the tissue is remodelled towards mature bone. [1] [2]

Who This Is Useful For

This page is useful for readers who want to understand how bone repair differs from ordinary bone turnover, why fracture healing may change with age, and which conclusions come from human tissue rather than animal models. It also provides context for separating osteoporosis, fracture risk, delayed union, and regenerative capacity.

What Bone Regeneration Involves

The route to union depends partly on the mechanical environment. Under very stable conditions, bone can heal through direct remodelling across the fracture line. More commonly, relative motion permits secondary healing: a haematoma and inflammatory response are followed by a cartilage-rich soft callus, replacement with woven bone, and prolonged remodelling into more organized lamellar bone. These phases overlap rather than functioning as a rigid sequence. [1]

Cells contributing to the callus arise from several local sources. Mouse lineage and transplantation studies show that the periosteum, the membrane surrounding bone, contains skeletal stem and progenitor cells with particularly strong regenerative activity after injury. Periosteal cells can contribute to both cartilage and bone during repair, while marrow and surrounding tissues also supply cells and signals. [2]

Age-Related Changes at a Glance

Skeletal Stem and Progenitor Cells

Repair requires local progenitors to proliferate and enter cartilage- and bone-forming lineages. A study of human callus samples from 61 patients aged 13 to 94 found that fracture-activated human skeletal stem-cell populations accumulated across ages. Advanced age was nevertheless associated with lower osteochondrogenic differentiation in culture and with transcriptional changes involving skeletogenic and senescence-related pathways. The finding points to altered cell function rather than simple absence of the population. [6]

Mouse studies provide stronger causal tests but a less direct model of human ageing. In one study, aged skeletal stem cells generated fewer bone and cartilage cells and more inflammatory stromal lineages. Young circulation or young blood-forming stem cells did not restore their osteochondrogenic activity, suggesting that some deficits were maintained within the aged skeletal lineage in that model. [7]

Inflammation, Macrophages, and Senescence

Acute inflammation is a required part of fracture repair, not merely an obstacle to it. Immune cells clear damaged tissue and provide signals that recruit and regulate progenitors. The relevant issue in ageing is therefore the timing, composition, and resolution of inflammation rather than its presence alone. [1] [5]

Human bone samples and mouse defect experiments have linked an age-associated inflammatory environment with fewer or less functional skeletal stem and progenitor cells. In the mouse component of that work, NF-kB-associated inflammation promoted cellular senescence and impaired osteogenic function. This supports a mechanism connecting chronic inflammation to regenerative decline, but it does not show that one inflammatory pathway explains all age-related impairment in people. [5]

Macrophages also change with age. Macrophages entering fractures in old mice had a more pro-inflammatory transcriptional profile, and reducing their influx improved bone formation in the callus. More recent mouse work identified grancalcin released by aged callus macrophages as one signal capable of inducing progenitor-cell senescence. These perturbation studies establish causal mechanisms in their experimental systems; they do not establish a clinical method for regenerating human bone. [8] [9]

Blood Vessels and the Regenerative Niche

Fracture healing and vascular growth are closely coupled. New vessels supply oxygen and nutrients, provide routes for circulating cells, and deliver local signals as cartilage is replaced by bone. In a mouse tibial-fracture study, juvenile calluses had a greater vessel surface density than middle-aged and old calluses, together with earlier expression of HIF-1 alpha, VEGF, and matrix-remodelling enzymes. [4]

These observations show that the vascular programme changes with age, but direction of causality is difficult to isolate. A smaller or slower-forming callus may develop fewer vessels, while a weaker vascular response may itself restrict callus growth. Both processes can occur together, and vascular measurements at selected time points cannot by themselves distinguish cause from consequence. [4]

Bone Ageing Is Not the Same as Failed Regeneration

Osteoporosis describes reduced bone strength and increased fracture susceptibility; delayed union and nonunion describe the course of repair after a fracture. These states can overlap because the same aged skeleton supplies the cells, matrix, vasculature, and mechanical substrate for healing, but one does not automatically imply the other. Fracture pattern, fixation stability, soft-tissue injury, infection, vascular supply, and other host factors also shape whether union occurs. [1] [10]

Clinical findings illustrate this distinction. Among 272 adults undergoing surgery for established long-bone nonunion, patients aged 65 or older had similar healing rates and time to union to younger patients after adjustment for measured factors. The study does not negate biological ageing effects: it shows that those effects can be modified or outweighed by injury characteristics, selection, and treatment in a particular clinical setting. [10]

Evidence Quality and Interpretation

Confidence is strong that bone repair is a multicellular, mechanically regulated process and that ageing changes several participating systems. Histology, lineage tracing, transplantation, gene expression, and functional perturbation studies consistently implicate progenitors, immune cells, and vessels. [1] [2] [5] [7]

Confidence is moderate that defects measured in older human skeletal stem cells contribute to impaired healing. Human callus studies provide direct biological relevance, but cell isolation and culture alter the niche, and associations with age cannot identify the contribution of every coexisting clinical factor. [5] [6]

Confidence is lower when a molecular rescue in mice is treated as evidence of benefit in older people. Experimental fractures are standardized, mouse healing is rapid, and interventions can be delivered at precisely controlled stages. Human fractures vary in anatomy, mechanics, tissue damage, health status, and treatment; clinical cohorts also show that age alone is an inconsistent predictor. [3] [7] [9] [10]

What This Does Not Mean

• It does not mean that an older person cannot achieve fracture union; chronological age is only one part of the clinical context. [10]
• It does not mean that more inflammation is always harmful; a coordinated early inflammatory response is necessary for repair. [1]
• It does not mean that osteoporosis and impaired healing are interchangeable outcomes. [1] [10]
• It does not mean that correcting one pathway in a mouse will reproduce whole-system regeneration in humans. [7] [9]

Summary

Bone regeneration after fracture depends on coordinated mechanical stability, inflammation, skeletal progenitors, vascular growth, cartilage and bone formation, and remodelling. Ageing can alter every part of this network, but its effects are heterogeneous rather than absolute. Animal studies reveal causal mechanisms, while human cell and clinical studies show both age-associated deficits and retained capacity. The most defensible interpretation is therefore that ageing changes the conditions under which bone regenerates, not that it switches regeneration off. [1] [6] [10]

References

1. Einhorn, T. A., & Gerstenfeld, L. C. (2015). Fracture healing: mechanisms and interventions. Nature Reviews Rheumatology. https://pmc.ncbi.nlm.nih.gov/articles/PMC4464690/
2. Duchamp de Lageneste, O., et al. (2018). Periosteum contains skeletal stem cells with high bone regenerative potential controlled by Periostin. Nature Communications. https://www.nature.com/articles/s41467-018-03124-z
3. Lu, C., et al. (2005). Cellular basis for age-related changes in fracture repair. Journal of Orthopaedic Research. https://pmc.ncbi.nlm.nih.gov/articles/PMC2844440/
4. Lu, C., et al. (2008). Effect of age on vascularization during fracture repair. Journal of Orthopaedic Research. https://pmc.ncbi.nlm.nih.gov/articles/PMC2846969/
5. Josephson, A. M., et al. (2019). Age-related inflammation triggers skeletal stem/progenitor cell dysfunction. Proceedings of the National Academy of Sciences. https://pmc.ncbi.nlm.nih.gov/articles/PMC6452701/
6. Ambrosi, T. H., et al. (2020). Geriatric fragility fractures are associated with a human skeletal stem cell defect. Aging Cell. https://pmc.ncbi.nlm.nih.gov/articles/PMC7370785/
7. Ambrosi, T. H., et al. (2021). Aged skeletal stem cells generate an inflammatory degenerative niche. Nature. https://www.nature.com/articles/s41586-021-03795-7
8. Clark, D., et al. (2020). Age-related changes to macrophages are detrimental to fracture healing in mice. Aging Cell. https://pmc.ncbi.nlm.nih.gov/articles/PMC7059136/
9. Zou, N.-Y., et al. (2024). Age-related secretion of grancalcin by macrophages induces skeletal stem/progenitor cell senescence during fracture healing. Bone Research. https://www.nature.com/articles/s41413-023-00309-1
10. Taormina, D. P., et al. (2014). Older age does not affect healing time and functional outcomes after fracture nonunion surgery. Geriatric Orthopaedic Surgery & Rehabilitation. https://pmc.ncbi.nlm.nih.gov/articles/PMC4212425/